TipRanks tools are all you need to make data-driven investment decisions. Conduct comprehensive stock research, find new investment ideas, analyze your portfolio, and follow the best-performing Wall Street experts, with ease.
The The Valens stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
Valens GroWorks Corp. is a biotechnology company. It is engaged in the provision of cannabis products developed from the firm's proprietary extraction techniques. The firm also offers management, consulting, testing, and support services to domestic and international licensees, as well as financing and managing the build out of fully-licensed third party operations. The company was founded on January 14, 1981 and is headquartered in Kelowna, Canada.
What was The Valens’s price range in the past 12 months?
The Valens lowest stock price was C$1.44 and its highest was C$4.00 in the past 12 months.
What is The Valens’s market cap?
The Valens’s market cap is C$474.90M.
What is The Valens’s price target?
The average price target for The Valens is C$3.62. This is based on 2 Wall Streets Analysts 12-month price targets, issued in the past 3 months. The highest analyst price target is C$4.25 ,the lowest forecast is C$3.00. The average price target represents 32.11% Increase from the current price of C$2.74.
What do analysts say about The Valens?
The Valens’s analyst rating consensus is a ‘Moderate Buy. This is based on the ratings of 2 Wall Streets Analysts.
When is The Valens’s upcoming earnings report date?
The Valens’s upcoming earnings report date is Oct 20, 2021 which is in 26 days.
How were The Valens’s earnings last quarter?
The Valens released its earnings results on Jul 14, 2021. The company reported -C$0.055 earnings per share for the quarter, missing the consensus estimate of -C$0.045 by -C$0.01.
Is The Valens overvalued?
According to Wall Street analysts The Valens’s price is currently Undervalued.
Does The Valens pay dividends?
The Valens does not currently pay dividends.
What is The Valens’s EPS estimate?
The Valens’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does The Valens have?
The Valens has 185,990,000 shares outstanding.
What happened to The Valens’s price movement after its last earnings report?
The Valens reported an EPS of -C$0.055 in its last earnings report, missing expectations of -C$0.045. Following the earnings report the stock price went down -5.639%.
Which hedge fund is a major shareholder of The Valens?
Currently, no hedge funds are holding shares in TSE:VLNS